Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine–A Study Protocol

Detalles Bibliográficos
Autores principales: Chopra, Arvind, Chavan-Gautam, Preeti, Tillu, Girish, Saluja, Manjit, Borse, Swapnil, Sarmukaddam, Sanjeev, Chaudhuri, Susmita, Rao, BCS, Yadav, Babita, Srikanth, Narayanam, Patwardhan, Bhushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005450/
https://www.ncbi.nlm.nih.gov/pubmed/35433723
http://dx.doi.org/10.3389/fmed.2022.888928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005450/
https://www.ncbi.nlm.nih.gov/pubmed/35433723
http://dx.doi.org/10.3389/fmed.2022.888928

Ejemplares similares